Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts NextSource Materials Announces Results of 2025 Annual Meeting of Shareholders January 1, 2026 Crypto Market Update: XRP and Solana ETFs Gain as Bitcoin, Ether Continue to Bleed January 1, 2026 CoTec Investment MagIron Completes Purchase of Reynolds Pellet Plant January 1, 2026